Risk factors

A direct customer’s share of sales rose from 15% to 18%, while top two customers and subcontractors’ share fell from 41% to 34%.

New tariffs and enhanced denied-party screening are affecting trade exposure and lengthening some customer transaction cycles.

ABM plans to acquire WGNSTAR in the first half of 2026 and flags execution, customer-retention, and employee-retention risks.

Staffing risks now include legal work-authorization shortages and effects on restaurant openings, sales growth and labor-cost goals.

Net loss increased from approximately $2.0 million in fiscal 2024 to $2.5 million in fiscal 2025; accumulated deficit rose from $92 million to $94 million.

LYTENAVA generated $1.4 million in fiscal 2025 sales in Germany and the UK, but the company says it has not generated material product revenue.

Shareholder redemptions and limited voting rights could let RAC complete a deal despite public investors’ opposition or undermine financing at closing.

Financing disclosures highlight a larger $2.35 billion revolving facility, 2030 facility and term-loan maturities, and $1.75 billion of notes due through 2035.

The risk section reflects a shift from glucose-monitoring products to Bitcoin holdings and a pre-launch tokenized-deposit initiative.

New tariff exposure could raise packaging costs or disrupt supply despite possible U.S. alternatives.

AI demand now raises both semiconductor delivery pressures and customer financing risks, including requests for alternative or deferred payment models.

Competition risk now notes suppliers and customers lack long-term contracts and can shift business to competitors at any time.